Small Fiber Neuropathy: Symptoms, Causes, and Treatment Options

You feel a burning sensation in your feet that no one can explain. Your hands tingle at odd times. You sweat too much, or not at all. You have seen multiple doctors, had nerve conduction studies that came back normal, and been told there is nothing wrong. If this sounds familiar, you may be dealing with small fiber neuropathy, a condition that affects the tiniest nerve fibers in your body and is frequently missed by standard neurological testing.

Small fiber neuropathy (SFN) is far more common than most people realize, and it is one of the most underdiagnosed neurological conditions in medicine today. This article explains what SFN is, how to recognize it, what causes it, how it is diagnosed, and what treatment options are available.

What Is Small Fiber Neuropathy?

Your peripheral nervous system contains different types of nerve fibers, classified by their size and function. Large fibers are myelinated (wrapped in an insulating sheath) and transmit signals about touch, vibration, and proprioception (your sense of where your body is in space). Small fibers, on the other hand, are either thinly myelinated (A-delta fibers) or unmyelinated (C fibers), and they serve two main functions [1]:

When these small fibers become damaged or degenerate, the result is small fiber neuropathy. Because standard nerve conduction studies (NCS) and electromyography (EMG) only measure large fiber function, patients with pure small fiber neuropathy can have completely normal results on these tests, leading doctors to conclude nothing is wrong [2].

This is one of the most frustrating aspects of the condition. Patients know something is off, but the standard workup does not detect it. A proper diagnosis requires specific testing that many general neurologists do not routinely perform.

Symptoms of Small Fiber Neuropathy

SFN symptoms fall into two broad categories: sensory symptoms and autonomic symptoms. Many patients experience both, though the severity and combination vary widely from person to person.

Sensory Symptoms

The hallmark of SFN is neuropathic pain, often described in vivid terms:

• Burning pain in the feet, hands, or other areas. This is the most commonly reported symptom. Patients often describe it as feeling like their feet are on fire or like they are walking on hot sand [3].
• Tingling and prickling (paresthesias), sometimes described as “pins and needles” that come and go without apparent cause.
• Electric shock-like sensations that occur spontaneously or in response to light touch.
• Allodynia, where normally painless stimuli (like bedsheets touching the feet or wearing socks) cause pain.
• Hyperalgesia, an exaggerated pain response to stimuli that should only be mildly painful.
• Numbness or reduced sensation, particularly in a “stocking-glove” distribution starting in the feet and hands.
• Itching that occurs without any visible skin cause and does not respond to typical anti-itch treatments.

Symptoms typically begin in the feet and may progress upward over time. In some cases, the hands are affected as well, and less commonly, the face, trunk, or patchy areas of the body may be involved [4].

Autonomic Symptoms

Because small fibers also control autonomic functions, SFN often produces a range of symptoms that may seem unrelated to a nerve problem. These can include [5]:

• Abnormal sweating. Either excessive sweating (hyperhidrosis) or reduced/absent sweating (anhidrosis), sometimes in patchy patterns across the body.
• Orthostatic intolerance. Dizziness, lightheadedness, or fainting upon standing, due to impaired blood pressure regulation.
• Heart rate abnormalities. Resting tachycardia (fast heart rate) or inappropriate heart rate responses to positional changes.
• Gastrointestinal dysfunction. Early satiety, nausea, bloating, constipation, diarrhea, or gastroparesis (delayed stomach emptying).
• Bladder dysfunction. Urinary urgency, frequency, or difficulty emptying the bladder.
• Dry eyes and dry mouth. Reduced tear and saliva production.
• Sexual dysfunction. Erectile dysfunction in men, reduced lubrication in women.
• Skin changes. Skin discoloration, dryness, or changes in hair growth patterns in affected areas.

The autonomic symptoms are often the most debilitating aspect of SFN. They are also the symptoms most likely to be attributed to other conditions or dismissed entirely.

What Causes Small Fiber Neuropathy?

The list of potential causes is long, and in roughly 30 to 50 percent of cases, no cause is identified (idiopathic SFN) [6]. However, identifying a treatable underlying cause, when one exists, is essential for effective management.

Metabolic Causes

• Diabetes and prediabetes. This is the most common identifiable cause. Even mild glucose dysregulation (impaired glucose tolerance) without a formal diabetes diagnosis can damage small fibers [7]. A glucose tolerance test is more sensitive than fasting glucose or HbA1c for detecting this.
• Vitamin B12 deficiency. Low B12 levels are a well-known cause of neuropathy. Methylmalonic acid and homocysteine levels are more sensitive markers than serum B12 alone.
• Thyroid disorders. Both hypothyroidism and hyperthyroidism have been associated with SFN.

Autoimmune and Inflammatory Causes

• Sjogren’s syndrome. This autoimmune condition, which primarily affects moisture-producing glands, is increasingly recognized as a major cause of SFN, sometimes predating other Sjogren’s symptoms by years [8].
• Celiac disease. Gluten sensitivity and celiac disease can cause SFN even without significant gastrointestinal symptoms.
• Sarcoidosis. This inflammatory condition can directly affect small nerve fibers.
• Lupus and rheumatoid arthritis. Various systemic autoimmune diseases can contribute to small fiber damage.
• Autoimmune autonomic ganglionopathy. Antibodies against ganglionic acetylcholine receptors can cause severe autonomic SFN.

Infectious Causes

• Hepatitis C. Chronic HCV infection is associated with SFN, sometimes through cryoglobulinemia.
• HIV. Both the virus itself and some antiretroviral medications can cause small fiber damage.
• Lyme disease. Borrelia burgdorferi infection can affect small fibers, though this remains a subject of ongoing research.

Genetic Causes

• Fabry disease. This X-linked lysosomal storage disorder causes SFN and is treatable with enzyme replacement therapy. It is often underdiagnosed and worth screening for, particularly in young patients with unexplained SFN [9].
• Hereditary sensory and autonomic neuropathies (HSAN). A group of rare genetic conditions that damage small fibers.
• SCN9A and SCN10A mutations. Mutations in sodium channel genes can cause gain-of-function changes that lead to SFN-like pain syndromes [10].

Toxic Causes

• Alcohol. Chronic excessive alcohol consumption is a well-established cause.
• Chemotherapy. Many chemotherapy agents, particularly platinum-based drugs and taxanes, damage small fibers.
• Medications. Certain antibiotics (metronidazole, nitrofurantoin), statins, and other medications have been associated with SFN.

Other Associations

• Fibromyalgia. Studies have found reduced small fiber density in a significant subset of fibromyalgia patients, suggesting that some cases of fibromyalgia may actually be SFN [11].
• Ehlers-Danlos syndrome. Hypermobile EDS has been increasingly linked to SFN.
• Post-viral syndromes. SFN has been reported following various viral infections, including COVID-19, with growing research in this area [12].

How Small Fiber Neuropathy Is Diagnosed

Getting the right diagnosis requires tests that specifically evaluate small fiber function. Here are the primary diagnostic tools.

Skin Punch Biopsy

This is the gold standard for diagnosing SFN [2]. A small (3mm) skin biopsy, usually taken from the ankle and thigh, is analyzed for intraepidermal nerve fiber density (IENFD). The procedure involves:

A reduced IENFD confirms the diagnosis of SFN. The procedure is simple, minimally invasive, and can be done in an office setting. A single stitch or adhesive strip closes the site, and healing typically takes about a week.

Quantitative Sudomotor Axon Reflex Test (QSART)

QSART evaluates the function of small autonomic fibers that control sweating [13]. During the test, a small electrical current stimulates sweat glands at four sites (forearm, proximal leg, distal leg, and foot), and the sweat output is precisely measured. Reduced or absent sweat production indicates small fiber autonomic dysfunction.

Quantitative Sensory Testing (QST)

QST measures thresholds for detecting temperature changes and vibration. Elevated warm and cool detection thresholds suggest small fiber dysfunction. While useful as a screening tool, QST is subjective (it relies on patient responses) and is not considered diagnostic on its own [14].

Corneal Confocal Microscopy

This non-invasive imaging technique examines the density and morphology of small nerve fibers in the cornea. It is painless and repeatable, making it useful for tracking disease progression [15].

Blood Work

While blood tests cannot diagnose SFN directly, they are essential for identifying underlying causes. A thorough workup typically includes fasting glucose, a 2-hour oral glucose tolerance test, HbA1c, vitamin B12 with methylmalonic acid, thyroid panel, inflammatory markers (ESR, CRP), autoimmune markers (ANA, SSA/SSB antibodies), celiac panel, hepatitis B and C, HIV, serum protein electrophoresis, alpha-galactosidase A (for Fabry disease), and angiotensin-converting enzyme (for sarcoidosis).

Treatment Options for Small Fiber Neuropathy

Treatment of SFN involves two parallel strategies: addressing the underlying cause (when identified) and managing symptoms.

Treating the Underlying Cause

When a specific cause is found, treating it can slow or even reverse nerve fiber damage:

• Glucose regulation. For diabetes and prediabetes-related SFN, tight glycemic control through diet, exercise, and medication when needed can halt progression and allow some fiber regrowth [7].
• Vitamin supplementation. B12 deficiency-related SFN responds well to B12 repletion (methylcobalamin is generally preferred over cyanocobalamin).
• Immunotherapy. For autoimmune-related SFN, treatments such as intravenous immunoglobulin (IVIG), corticosteroids, or other immunomodulatory therapies may help. A 2012 study showed that IVIG improved both pain and skin biopsy nerve fiber density in autoimmune SFN [8].
• Gluten-free diet. For celiac-related SFN, strict gluten avoidance can lead to symptom improvement.
• Enzyme replacement therapy. For Fabry disease, enzyme replacement can address the underlying metabolic defect.

Symptom Management: Pain

Neuropathic pain from SFN can be challenging to treat, and finding the right approach often requires patience and trial of multiple options:

• First-line medications include duloxetine (Cymbalta), pregabalin (Lyrica), and gabapentin (Neurontin). These work by modulating pain signaling in the central nervous system [3].
• Topical treatments such as capsaicin cream (0.075% or 8% patch) and lidocaine patches can provide localized relief with fewer systemic side effects.
• Tricyclic antidepressants like amitriptyline and nortriptyline are older but effective options, particularly for nighttime pain.
• SNRIs (serotonin-norepinephrine reuptake inhibitors) beyond duloxetine, such as venlafaxine, may help.
• Low-dose naltrexone (LDN). Emerging evidence suggests LDN (1.5 to 4.5 mg) may help with neuropathic pain through modulation of glial cell activity and endorphin regulation, though large controlled trials are still needed [4].
• Alpha-lipoic acid. This antioxidant has shown modest benefit for diabetic neuropathy pain at doses of 600 mg daily [7].

Symptom Management: Autonomic Dysfunction

Autonomic symptoms require targeted approaches:

• Orthostatic intolerance. Increased salt and fluid intake, compression stockings, and medications such as fludrocortisone or midodrine can help.
• Gastroparesis. Small, frequent meals, dietary modifications, and prokinetic agents.
• Sweating abnormalities. Cooling vests, climate management, and in some cases medications.
• Bladder dysfunction. Timed voiding, pelvic floor exercises, and sometimes medications.

Emerging and Regenerative Approaches

Research into nerve fiber regeneration is active and promising:

• Photobiomodulation (cold laser therapy). Low-level laser therapy has shown potential for nerve regeneration and pain reduction in peripheral neuropathy.
• Platelet-rich plasma (PRP). Early research suggests PRP injections may support nerve healing.
• Exercise. Regular moderate exercise has been shown to increase intraepidermal nerve fiber density in some studies, making it one of the few interventions that may directly promote nerve regrowth [7].

Living with Small Fiber Neuropathy

SFN is a chronic condition that requires ongoing management, but many patients find significant relief with the right combination of treatments. Here are some practical tips:

When to See a Doctor

Seek medical evaluation if you experience:

• Persistent burning, tingling, or pain in your feet or hands, especially if nerve conduction studies have been normal
• Unexplained sweating changes, dizziness upon standing, or other autonomic symptoms
• Rapid onset or worsening of neuropathic symptoms
• Neuropathy symptoms combined with systemic complaints (joint pain, dry eyes, rashes) that might suggest an autoimmune condition
• Any loss of sensation that increases your risk of injury

If your primary care doctor is not familiar with SFN, ask for a referral to a neurologist, ideally one who specializes in peripheral neuropathy and has experience with skin biopsy diagnosis. Neuromuscular specialists and some functional medicine practitioners are well versed in the workup and management of SFN.

Do not accept “your nerve conduction study is normal, so there is nothing wrong” as a final answer. If your symptoms fit the pattern described in this article, a skin biopsy and autonomic testing can provide the clarity you need.

—

References

[1] Lauria, G., & Lombardi, R. (2012). Small fiber neuropathy: Is skin biopsy the holy grail? Current Diabetes Reports, 12(4), 384-392. PMID: 22528671

[2] Devigili, G., Tugnoli, V., Penza, P., Camozzi, F., Lombardi, R., Melli, G., … & Lauria, G. (2008). The diagnostic criteria for small fibre neuropathy: From symptoms to neuropathology. Brain, 131(7), 1912-1925. PMID: 18524793

[3] Terkelsen, A. J., Karlsson, P., Lauria, G., Freeman, R., Finnerup, N. B., & Jensen, T. S. (2017). The diagnostic challenge of small fibre neuropathy: Clinical presentations, evaluations, and causes. The Lancet Neurology, 16(11), 934-944. PMID: 29029847

[4] Oaklander, A. L., & Nolano, M. (2019). Scientific advances in and clinical approaches to small-fiber polyneuropathy: A review. JAMA Neurology, 76(10), 1240-1251. PMID: 31498378

[5] Thaisetthawatkul, P., Fernandes Filho, J. A., & Engel, A. G. (2013). Contribution of QSART to the diagnosis of small fiber neuropathy. Muscle & Nerve, 48(6), 883-888. PMID: 23649502

[6] de Greef, B. T. A., Hoeijmakers, J. G. J., Gorber, C., Gerrits, M. M., Faber, C. G., & Merkies, I. S. J. (2018). Associated conditions in small fiber neuropathy: A large cohort study and review of the literature. European Journal of Neurology, 25(2), 348-355. PMID: 29112785

[7] Singleton, J. R., Marcus, R. L., Jackson, J. E., Lessard, M. K., Graham, T. E., & Smith, A. G. (2014). Exercise increases cutaneous nerve fiber density in diabetic patients without neuropathy. Annals of Clinical and Translational Neurology, 1(10), 844-849. PMID: 25493275

[8] Levine, T. D., Saperstein, D. S., Gronseth, G., Barohn, R. J., & Nations, S. P. (2020). Small fiber neuropathy, fibromyalgia, and autoimmunity. Annals of Neurology, 87(5), 326-327.

[9] Zarate, Y. A., & Hopkin, R. J. (2008). Fabry’s disease. The Lancet, 372(9647), 1427-1435. PMID: 18940466

[10] Faber, C. G., Hoeijmakers, J. G. J., Ahn, H. S., Cheng, X., Han, C., Choi, J. S., … & Waxman, S. G. (2012). Gain of function Nav1.7 mutations in idiopathic small fiber neuropathy. Annals of Neurology, 71(1), 26-39. PMID: 21698661

[11] Oaklander, A. L., Herzog, Z. D., Downs, H. M., & Klein, M. M. (2013). Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain, 154(11), 2310-2316. PMID: 23748113

[12] Abrams, R. M. C., Simpson, D. M., Navis, A., Jette, N., Zhou, L., & Shin, S. C. (2022). Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle & Nerve, 65(4), 440-443. PMID: 35037282

[13] Low, P. A. (2004). Evaluation of sudomotor function. Clinical Neurophysiology, 115(7), 1506-1513. PMID: 15203050

[14] Backonja, M. M., Attal, N., Baron, R., Bouhassira, D., Drangholt, M., Dyck, P. J., … & Ziegler, D. (2013). Value of quantitative sensory testing in neurological and pain disorders. Pain, 154(9), 1807-1819. PMID: 23742795

[15] Tavakoli, M., Quattrini, C., Abbott, C., Kallinikos, P., Marshall, A., Finnigan, J., … & Malik, R. A. (2010). Corneal confocal microscopy: A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care, 33(8), 1792-1797. PMID: 20435796